4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Iovance Biotherapeutics, Inc. (IOVA) operates in the Biotechnology industry and is headquartered in San Carlos, United States with about 975 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, IOVA reported $264M in revenue and ($391M) in net income.
Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally.
Interactive charts & full statements → Open the IOVA valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $264M | $164M | $1M | $0M | — |
| Gross Profit | $90M | $71M | $0M | $0M | — |
| Operating Income (EBIT) | ($398M) | ($395M) | ($461M) | ($399M) | — |
| Net Income | ($391M) | ($372M) | ($444M) | ($396M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $71M | $87M | $68M | $60M | $49M |
| Gross Profit | $29M | $44M | $29M | $3M | $7M |
| Operating Income (EBIT) | ($81M) | ($74M) | ($90M) | ($114M) | ($121M) |
| Net Income | ($79M) | ($72M) | ($91M) | ($112M) | ($116M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $913M | $910M | $780M | $664M | — |
| Total Liabilities | $215M | $200M | $196M | $164M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IOVA viewer.
About TickerBase · Data methodology & sources